Retrospective analysis to assess the feasibility of escalated dose of nimotuzumab in patients with locally advanced head and neck cancer

Retrospective analysis to assess the feasibility of escalated dose of nimotuzumab in patients with locally advanced head and neck cancer

Introduction: Head and neck cancer (HNC) has large worldwide prevalence and accounts for almost 5% among all types of cancers. Nimotuzumab is a humanized anti-epidermal growth factor receptor monoclonal antibody that has shown promising results in patients with HNC. The present retrospective case st...

Full description

Bibliographic Details
Main Authors: Nagraj Gururaj Huilgol, Ajit Nair, Sameer Chaudhari, Dilip Pawar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Radiation and Cancer Research
Subjects:
Anti-epidermal growth factor receptor
epidermal growth factor receptor
head and neck cancer
nimotuzumab
Online Access:http://www.journalrcr.org/article.asp?issn=0973-0168;year=2017;volume=8;issue=2;spage=108;epage=111;aulast=Huilgol

Internet

http://www.journalrcr.org/article.asp?issn=0973-0168;year=2017;volume=8;issue=2;spage=108;epage=111;aulast=Huilgol

Similar Items